Related Experiment Video
Updated: Jan 3, 2026

Quantitative Autoradiographic Method for Determination of Regional Rates of Cerebral Protein Synthesis In Vivo
Published on: June 28, 2019
Methionine sulfoxide reductase (Msr) dysfunction in human brain disease
Melissa Reiterer1, Rainald Schmidt-Kastner2, Sarah L Milton1
1Charles E. Schmidt College of Science, Florida Atlantic University, Boca Raton, FL, USA.
Abstract:
Extensive research has shown that oxidative stress is strongly associated with aging, senescence and several diseases, including neurodegenerative and psychiatric disorders. Oxidative stress is caused by the overproduction of reactive oxygen species (ROS) that can be counteracted by both enzymatic and nonenzymatic antioxidants. One of these antioxidant mechanisms is the widely studied methionine sulfoxide reductase system (Msr). Methionine is one of the most easily oxidized amino acids and Msr can reverse this oxidation and restore protein function, with MsrA and MsrB reducing different stereoisomers. This article focuses on experimental and genetic research performed on Msr and its link to brain diseases. Studies on several model systems as well as genome-wide association studies are compiled to highlight the role of MSRA in schizophrenia, Alzheimer's disease, and Parkinson's disease. Genetic variation of MSRA may also contribute to the risk of psychosis, personality traits, and metabolic factors.
Insights
Oxidative stress contributes to aging and brain diseases. The methionine sulfoxide reductase system (Msr), particularly MSRA, plays a crucial role in protecting against these conditions, impacting risks for schizophrenia and Alzheimer's disease.
Area of Science:
- Biochemistry
- Neuroscience
- Genetics
Background:
- Oxidative stress, an imbalance between reactive oxygen species (ROS) and antioxidants, is linked to aging, senescence, and various diseases.
- The methionine sulfoxide reductase (Msr) system, comprising MsrA and MsrB, is a key antioxidant mechanism that repairs oxidized methionine residues in proteins.
- Methionine oxidation can impair protein function, and its reversal by Msr is vital for cellular health.
Purpose of the Study:
- To review experimental and genetic evidence linking the Msr system, specifically MSRA, to brain diseases.
- To highlight the role of MSRA in neurodegenerative conditions like Alzheimer's and Parkinson's diseases, and psychiatric disorders such as schizophrenia.
- To explore the potential contribution of MSRA genetic variations to psychosis, personality traits, and metabolic factors.
Main Methods:
- Compilation of experimental research on Msr function in model systems.
- Analysis of genetic studies, including genome-wide association studies (GWAS).
- Review of literature connecting MSRA genetic variations to disease risk and related traits.
Main Results:
- MSRA is implicated in the pathophysiology of schizophrenia, Alzheimer's disease, and Parkinson's disease.
- Genetic variations in MSRA are associated with an increased risk of psychosis.
- MSRA's role extends to influencing personality traits and metabolic factors.
Conclusions:
- The methionine sulfoxide reductase system, particularly MSRA, is a critical antioxidant defense in the brain.
- Dysregulation or genetic variations in MSRA contribute to the risk and progression of major brain disorders.
- Targeting Msr pathways may offer therapeutic strategies for neurodegenerative and psychiatric conditions.
More Related Videos
06:53Visualization of Mitochondrial Respiratory Function using Cytochrome C Oxidase / Succinate Dehydrogenase COX/SDH Double-labeling Histochemistry
Published on: November 23, 2011
11:49Quantitative Proteomics Workflow using Multiple Reaction Monitoring Based Detection of Proteins from Human Brain Tissue
Published on: August 28, 2021
Related Concept Videos
Sulfur Assimilation
Protein Import into the Peroxisomes
Peroxisomal Protein Import:
Peroxisomes lack the genetic machinery required to code for their own proteins. Hence, most peroxisomal membrane, lumenal and transmembrane proteins are synthesized in the cytoplasm or ER and transported to the peroxisome...